Literature DB >> 24354576

Role of fibroblast growth factors in elicitation of cell responses.

C Laestander1, W Engström.   

Abstract

Fibroblast growth factors (FGFs) are signalling peptides that control important cell processes such as proliferation, differentiation, migration, adhesion and survival. Through binding to different types of receptor on the cell surface, these peptides can have different effects on a target cell, the effect achieved depending on many features. Thus, each of the known FGFs elicits specific biological responses. FGF receptors (FGFR 1-5) initiate diverse intracellular pathways, which in turn lead to a variety of results. FGFs also bind the range of FGFRs with a series of affinities and each type of cells expresses FGFRs in different qualitative and quantitative patterns, which also affect responses. To summarize, cell response to binding of an FGF ligand depends on type of FGF, FGF receptor and target cell, all interacting in concert. This review aims to examine properties of the FGF family and its members receptors. It also aims to summarize features of intracellular signalling and highlight differential effects of the various FGFs in different circumstances.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24354576      PMCID: PMC6495704          DOI: 10.1111/cpr.12084

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  83 in total

Review 1.  Signalling by receptor tyrosine kinases.

Authors:  W J Fantl; D E Johnson; L T Williams
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

2.  Identification of a new fibroblast growth factor receptor, FGFR5.

Authors:  M Sleeman; J Fraser; M McDonald; S Yuan; D White; P Grandison; K Kumble; J D Watson; J G Murison
Journal:  Gene       Date:  2001-06-27       Impact factor: 3.688

3.  Requirement of FGF-4 for postimplantation mouse development.

Authors:  B Feldman; W Poueymirou; V E Papaioannou; T M DeChiara; M Goldfarb
Journal:  Science       Date:  1995-01-13       Impact factor: 47.728

4.  Relevant use of Klotho in FGF19 subfamily signaling system in vivo.

Authors:  Ken-ichi Tomiyama; Ryota Maeda; Itaru Urakawa; Yuji Yamazaki; Tomohiro Tanaka; Shinji Ito; Yoko Nabeshima; Tsutomu Tomita; Shinji Odori; Kiminori Hosoda; Kazuwa Nakao; Akihiro Imura; Yo-ichi Nabeshima
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-08       Impact factor: 11.205

5.  Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver.

Authors:  Yuhei Hotta; Hirotoshi Nakamura; Morichika Konishi; Yusuke Murata; Hiroyuki Takagi; Shigenobu Matsumura; Kazuo Inoue; Tohru Fushiki; Nobuyuki Itoh
Journal:  Endocrinology       Date:  2009-07-09       Impact factor: 4.736

6.  Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones.

Authors:  Paul A Dutchak; Takeshi Katafuchi; Angie L Bookout; Jang Hyun Choi; Ruth T Yu; David J Mangelsdorf; Steven A Kliewer
Journal:  Cell       Date:  2012-02-03       Impact factor: 41.582

7.  Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB.

Authors:  Chaofeng Yang; Chengliu Jin; Xiaokun Li; Fen Wang; Wallace L McKeehan; Yongde Luo
Journal:  PLoS One       Date:  2012-03-19       Impact factor: 3.240

8.  Fibroblast growth factor 2 causes G2/M cell cycle arrest in ras-driven tumor cells through a Src-dependent pathway.

Authors:  Jacqueline Salotti; Matheus H Dias; Marianna M Koga; Hugo A Armelin
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

9.  FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment.

Authors:  Tilo Kunath; Marc K Saba-El-Leil; Marwa Almousailleakh; Jason Wray; Sylvain Meloche; Austin Smith
Journal:  Development       Date:  2007-08       Impact factor: 6.868

10.  Differential effects of epidermal growth factor (EGF) on cell locomotion and cell proliferation in a cloned human embryonal carcinoma-derived cell line in vitro.

Authors:  W Engström
Journal:  J Cell Sci       Date:  1986-12       Impact factor: 5.285

View more
  9 in total

1.  Smad signal pathway regulates angiogenesis via endothelial cell in an adipose-derived stromal cell/endothelial cell co-culture, 3D gel model.

Authors:  Shiyu Lin; Jing Xie; Tao Gong; Sirong Shi; Tao Zhang; Na Fu; Yunfeng Lin
Journal:  Mol Cell Biochem       Date:  2015-12-22       Impact factor: 3.396

2.  Discovery of Substituted 1H-Pyrazolo[3,4-b]pyridine Derivatives as Potent and Selective FGFR Kinase Inhibitors.

Authors:  Bin Zhao; Yixuan Li; Pan Xu; Yang Dai; Cheng Luo; Yiming Sun; Jing Ai; Meiyu Geng; Wenhu Duan
Journal:  ACS Med Chem Lett       Date:  2016-04-20       Impact factor: 4.345

3.  Fibroblast growth factor 9 (FGF9) regulation of cyclin D1 and cyclin-dependent kinase-4 in ovarian granulosa and theca cells of cattle.

Authors:  M L Totty; B C Morrell; L J Spicer
Journal:  Mol Cell Endocrinol       Date:  2016-11-03       Impact factor: 4.102

4.  Gas-Phase Analysis of the Complex of Fibroblast GrowthFactor 1 with Heparan Sulfate: A Traveling Wave Ion Mobility Spectrometry (TWIMS) and Molecular Modeling Study.

Authors:  Yuejie Zhao; Arunima Singh; Yongmei Xu; Chengli Zong; Fuming Zhang; Geert-Jan Boons; Jian Liu; Robert J Linhardt; Robert J Woods; I Jonathan Amster
Journal:  J Am Soc Mass Spectrom       Date:  2016-09-23       Impact factor: 3.109

5.  Homology modeling and virtual screening studies of FGF-7 protein-a structure-based approach to design new molecules against tumor angiogenesis.

Authors:  Rajender Vadija; Kiran Kumar Mustyala; Navaneetha Nambigari; Ramasree Dulapalli; Rama Krishna Dumpati; Vishwanath Ramatenki; Santhi Prada Vellanki; Uma Vuruputuri
Journal:  J Chem Biol       Date:  2016-06-18

6.  BMP signaling in astrocytes downregulates EGFR to modulate survival and maturation.

Authors:  Anja R Scholze; Lynette C Foo; Sara Mulinyawe; Ben A Barres
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

7.  Fibroblast Growth Factor (FGF) 23 Regulates the Plasma Levels of Parathyroid Hormone In Vivo Through the FGF Receptor in Normocalcemia, But Not in Hypocalcemia.

Authors:  Maria L Mace; Eva Gravesen; Anders Nordholm; Klaus Olgaard; Ewa Lewin
Journal:  Calcif Tissue Int       Date:  2017-10-23       Impact factor: 4.333

8.  Design, synthesis and biological evaluation of 4-bromo-N-(3,5-dimethoxyphenyl)benzamide derivatives as novel FGFR1 inhibitors for treatment of non-small cell lung cancer.

Authors:  Zixin Xie; Donghua Cheng; Lu Luo; Guoliang Shen; Suwei Pan; Yaqian Pan; Bo Chen; Xuebao Wang; Zhiguo Liu; Yuan Zhang; Faqing Ye
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

9.  Design, Synthesis and Biological Evaluation of 6-(2,6-Dichloro-3,5-dimethoxyphenyl)-4-substituted-1H-indazoles as Potent Fibroblast Growth Factor Receptor Inhibitors.

Authors:  Zhen Zhang; Dongmei Zhao; Yang Dai; Maosheng Cheng; Meiyu Geng; Jingkang Shen; Yuchi Ma; Jing Ai; Bing Xiong
Journal:  Molecules       Date:  2016-10-23       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.